Every formulation is developed with a focus on safety, efficacy, and patient well-being, ensuring reliable healthcare solutions for healthcare professionals and consumers across India.
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
The earlier phase 3 study tested two doses against placebo, and the results ran the opposite way to intuition: 0.05 mg/kg/day met the primary endpoint (16/35 responders, p=0.007) while the higher 0.10 mg/kg/day dose failed it (8/32, p=0.16) [3]
The US trial (n=94) showed median 69.4 hours versus 40.8 hours of pain-free sun exposure
Inject the entire solution into the spray bottle